Suicide attempts and other self-harm may increase among men under the age of 40 in states that allow recreational use of marijuana, particuarly those with for-profit dispensaries, Stanford study suggests.
Stanford Medicine researchers have found a new way to stabilize mRNA molecules, something that could boost COVID vaccines.
Stanford Medicine researchers and collaborators aiming to predict and detect COVID-19 through smartwatch data expand user base into Pac-12 athletes.
Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
Stanford Medicine science writer Tracie White shares the origins of her new book that explores ME/CFS, family bonds, science, suffering, and much more.
Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …
Young scientists contributed to research that revealed the structures of enzymes behind the common disorder G6PD deficiency.
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
Blood levels of a brain-derived substance in people in their 90s and 100s accurately predict how much longer they're going to live.
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
A Stanford-led study of twins with and without food allergies has uncovered differences in the fecal bacteria of allergic and non-allergic individuals.
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.